Forge Life Science Partners is a venture capital firm that builds partnerships with outstanding life science entrepreneurs, founders, and operators to create the next generation of groundbreaking therapeutics. It is part of the B-FLEXION Group and its team includes experienced biotech investors, operators, and entrepreneurs with decades of experience in drug discovery and development.
80% of their portfolio is in Biotech & Life Sciences. They made 2 investments in the last 12 months. Their most common stage is series-b (60% of deals). Average disclosed round size is $95.6M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
2
Team
Anand Mehra
Founding Partner
Ben Auspitz
Venture Partner
Heather Berger
Venture Partner
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Kinaset Therapeutics | Series B | $103M | Jan 2026 |
| KKinaset | Series B | $103M | Jan 2026 |
 OnCusp | Series A | $100M | Jan 2024 |
 IDRx | Series A | $122M | — |
 Khartis Therapeutics | Series B | $50M | — |
Top Co-Investors
Last updated: 9 September 2026